Alexion Pharmaceuticals Inc. (ALXN)

Alexion Pharmaceuticals Inc. (ALXN $182.50)
- $182.50 Fwd P/E: 54.68X Cap: $40.33B
- View ALXN Profile
- View Questions on ALXN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Alexion Pharmaceuticals Inc. (ALXN $182.50)
- $182.50 Fwd P/E: 54.68X Cap: $40.33B
- View ALXN Profile
- View Questions on ALXN
Regeneron Pharmaceuticals Inc. (REGN $547.96)
- $547.96 Fwd P/E: 14.5X Cap: $59.16B
- View REGN Profile
- View Questions on REGN

Q: HI 5i Team,
In my USD account I hold REGN and ABBV @ 3.5%. I am considering adding ALXN growth. What is your opinion of this stock? If not this then any alternative? Dividends are not a priority.
Over the last 3 year of my membership, have immensely benefitted from your advice. Keep up the good work.
RR

Read Answer Asked by Rajinder on November 02, 2020

Alexion Pharmaceuticals Inc. (ALXN $182.50)
- $182.50 Fwd P/E: 54.68X Cap: $40.33B
- View ALXN Profile
- View Questions on ALXN

Q: The stock down 11% but i can't find a reason. The rumour about Amgen was a week ago and Alxn's fundamentals look solid. Any ideas?

Read Answer Asked by hal on September 03, 2019

Alexion Pharmaceuticals Inc. (ALXN $182.50)
- $182.50 Fwd P/E: 54.68X Cap: $40.33B
- View ALXN Profile
- View Questions on ALXN
Amgen Inc. (AMGN $292.51)
- $292.51 Fwd P/E: 27.08X Cap: $157.28B
- View AMGN Profile
- View Questions on AMGN
Biogen Inc. (BIIB $127.50)
- $127.50 Fwd P/E: 13.15X Cap: $18.68B
- View BIIB Profile
- View Questions on BIIB
Celgene Corporation (CELG $108.24)
- View CELG Profile
- View Questions on CELG

Q: My biotech holdings include Celegene at 3% and alexion at 1.5%. I am looking to obtain a basket of these stocks, the best in your opinion, as opposed to getting the sector etf.
My question are as follows:
1. Do you feel now is an opportune time to be adding to biotech, or has the sector run up too far?
2. If the time is right, what would be your top complementary picks to my current positions ( mid cap to large cap) and how many should I hold? Please advise what an adequate overall portfolio position would be for the sector, for an investor with a palate for moderate risk and a long way term view.

Thank you for your counsel,
Karim .

Read Answer Asked by Karim on October 03, 2017